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Kim de Haan1*, AB Johan Groeneveld2, Hilde RH de Geus3, Mohamud Egal3 and Ard Struijs1Abstract
Introduction: In Europe, vitamin D deficiency is highly prevalent varying between 40% and 60% in the healthy
general adult population. The consequences of vitamin D deficiency for sepsis and outcome in critically ill patients
remain controversial. We therefore systematically reviewed observational cohort studies on vitamin D deficiency in
the intensive care unit.
Methods: Fourteen observational reports published from January 2000 to March 2014, retrieved from Pubmed and
Embase, involving 9,715 critically ill patients and serum 25-hydroxyvitamin D3 (25 (OH)-D) concentrations, were
meta-analysed.
Results: Levels of 25 (OH)-D less than 50 nmol/L were associated with increased rates of infection (risk ratio (RR)
1.49, 95% (confidence interval (CI) 1.12 to 1.99), P = 0.007), sepsis (RR 1.46, 95% (CI 1.27 to 1.68), P <0.001), 30-day
mortality (RR 1.42, 95% (CI 1.00 to 2.02), P = 0.05), and in-hospital mortality (RR 1.79, 95% (CI 1.49 to 2.16), P <0.001).
In a subgroup analysis of adjusted data including vitamin D deficiency as a risk factor for 30-day mortality the
pooled RR was 1.76 (95% CI 1.37 to 2.26, P <0.001).
Conclusions: This meta-analysis suggests that vitamin D deficiency increases susceptibility for severe infections and
mortality of the critically ill.Introduction
Vitamin D deficiency, defined as serum 25-hydroxyvitamin
D3 (25 (OH)-D) concentrations below 50 nmol/L, is highly
prevalent in Dutch critically ill patients [1]. Several studies
in critically ill patients report associations between vitamin
D deficiency, a disturbed parathyroid hormone (PTH)-vita-
min D axis and increased mortality [2-5]. A biological basis
how hypovitaminosis D may cause mortality could be
hypocalcaemia. Hypocalcaemia is a well-known abnormal-
ity in critically ill patients in the course of sepsis and
rhabdomyolysis [6]. Second, vitamin D regulates both in-
nate and adaptive immune systems. Vitamin D deficiency
leads to immune dysregulation and has been proposed as
an underlying pathogenic mechanism of infections [7].
Third, vitamin D deficiency is associated with increased
markers of systemic inflammation associated with multi-* Correspondence: k.dehaan@erasmusmc.nl
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unless otherwise stated.organ failure [8]. Moreover hypovitaminosis D reduces,
despite maximal upregulation of PTH levels, formation of
1,25-dihydroxyvitamin D3 (1,25 (OH)-D) at the tissue level.
This may be critical in mediating the beneficial pleiotropic
functions of vitamin D, involving innate immunity, mucosal
barrier and endothelial function. Recently, a systematic re-
view and meta-analysis including observational and inter-
ventional studies on vitamin D in non-critically ill patients,
suggests an association of deficiency with cardiovascular
diseases, diabetes, and all-cause mortality in the former but
not in the latter studies [9]. In non-critically ill patients, of a
prior meta-analysis of 18 randomised controlled trials, in-
take of supplementary doses of vitamin D was associated
with a 7% decrease in mortality [10].
Therefore, we conducted a systematic review to pool
the available data and to study the possible effect of vita-
min D deficiency in critically ill patients on the inci-
dence of infection, sepsis and association with mortality.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Search strategy
The report of this protocol-driven systematic review and
meta-analysis follows the Preferred Reporting Items for
Systematic reviews and Meta-Analyses (PRISMA) and
Meta-analysis Of Observational Studies in Epidemiology
guidelines (MOOSE) [11]. A Medline, Embase and
Cochrane Library search was conducted with the help
of biomedical information specialists, limited to publi-
cations from January 2000 until March 2014 in humans.
The search consisted of two terms: vitamin D and inten-
sive care. The controlled thesaurus terms we used for
vitamin D were vitamin D and vitamin D deficiency.
The concept intensive care was covered by the following
keywords: intensive care unit (ICU), intensive care nurs-
ing, critical care and critically ill patients. For Medical
Subject Heading (MeSH) terms and search strategy see
S1 Table 1 in Additional file 1. References of included
articles were cross-checked for other relevant studies.
One author [12] was successfully contacted twice be-
cause not all required information could be retrieved
from the publication.
Study selection
Two independent authors, a researcher (KdH) and an
intensivist (AS) screened titles and abstracts for eligibility.
In case of disagreement, agreement of a third author (ME)
provided a final option. Studies eligible for inclusion in
the systematic review were observational studies describ-
ing ICU patients, reporting on serum 25 (OH)-D concen-
trations, outcomes, and those written in English. Studies
in which participants were younger than 18 years, sample
size was less than 20 patients and participants suffered
from parathyroid disease, human immunodeficiency virus
infection and end-stage renal disease requiring chronic
dialysis were excluded. Abstracts, letters, reviews and con-
ference articles were excluded as well.
Definitions
In this meta-analysis vitamin D deficiency was a priori de-
fined as a reported serum concentration <50 nmol/L, as ad-
vocated by the American Institute of Medicine [13].
However, the included studies unfortunately reported a
wide range of cutoffs for vitamin D deficiency. Prior to ana-
lysing the data for each study, agreement was negotiated
between two authors, KdH and AS, which vitamin D cut-
offs to be used in the meta-analysis, see Table 1. Due to the
designed search strategy, there was no clear definition of in-
fection and sepsis between included studies. The reported
occurrence of infections comprised any kind of infections
such as pneumonia, urinary tract, bacteraemia and intra-
abdominal infections. The included studies defined sepsis
varying from having positive blood cultures or systemic in-
flammatory response syndrome (SIRS) criteria combinedwith a source of infection. We reported the complete over-
view of definitions used in S2 Table 2 in Additional file 1.
Mortality rates were extracted as in-hospital and 30-day
mortality. Thirty-day mortality rates are well described and
defined in the included articles. All other definitions of
mortality, like ICU mortality, in-hospital mortality, acute in-
hospital mortality, were taken together as in-hospital mortal-
ity. When articles separately reported ICU and in-hospital
mortality, we combined numbers together in the analysis as
in-hospital mortality.
Statistical analysis
Review Manager (version 5.2 for Windows, The Cochrane
Collaboration, 2011) was used for the analysis. Occurrence
of infections, sepsis and mortality, as defined in the stud-
ies, was calculated for each individual study and the esti-
mated risk ratios (RRs) were pooled comparing the effect
of deficient levels (sufficient levels as reference) of 25
(OH)-D with the use of the inverse variance (IV) method
in a random-effects model, yielding RRs and 95% confi-
dence intervals (CIs). The IV method was used because of
the assumption that less variance in a study should con-
tribute to its weight in significance. A random-effects
model was used due to expected heterogeneity between
studies. If raw data was not available to calculate the RRs,
we used the reported odds ratios (ORs) and converted the
reported ORs to RRs with corresponding 95% CIs. Other-
wise, we manually calculated the RRs from the available
data. Additionally, taking confounding into account, we
decided to perform a subgroup analysis of adjusted data
reported on 30-day mortality. Unfortunately, most studies
do not report adjusted data on infections, sepsis and in-
hospital mortality, so we were not able to make a sub-
group analysis of those. Subgroup analyses were
performed to examine the difference per outcome based
on study design. To determine publication bias we used
funnel plots (Figures S3-S7 in Additional file 1). Hetero-
geneity was assessed with the use of the Cochran Q statis-
tics and the I2 test. We used the Newcastle-Ottawa scale
to evaluate the quality of included studies. This scale uses
a star system (with a maximum of nine stars) to evaluate a
study in three domains: selection of participants, compar-
ability of study groups, and the ascertainment of outcomes
of interest. We judged studies that received a score of nine
or eight stars to be at low risk of bias, studies that scored
seven or six stars to be at medium risk, and scores below
six to be at high risk of bias (S8a,b in Additional file 1).
Results
Search strategy
A total of 381 studies were screened; 358 were excluded for
the following reasons: irrelevant (n = 229), review (n = 7),
study design or too small in sample size (n = 26), only fo-
cused on vitamin D metabolism (n = 45), pediatric studies
Table 1 Overview of publications used in the meta-analysis
Author Year of
publication
Study population Study design Number of patients Endpoints Comparison
(in meta-analysis)
Study*
quality
Amrein et al. [25] 2014 Medical, surgical ICU Retrospective, cohort 655 Sepsis, in-hospital mortality <50 nmol/l vs >75 nmol/l 7
Arnson et al. [21] 2012 Medical, surgical ICU Prospective, cohort 130 Infections ≤50 nmol/l vs >50 nmol/l 6
Aygencel et al. [24] 2013 Medical ICU Prospective, cohort 201 Infections, sepsis, in-hospital mortality <50 nmol/l vs ≥50 nmol/l 4
Braun et al. [5] 2012 Medical, surgical ICU Two-centre, retrospective, cohort 1,325 Sepsis, 30-day, in-hospital mortality ≤37 nmol/l vs ≥75 nmol/l 8
Braun et al. [3] 2011 Surgical ICU Two-centre, retrospective, cohort 2,399 Infections, 30-day, in-hospital mortality ≤37 nmol/l vs ≥75 nmol/l 8
Flynn et al. [22] 2012 Medical, surgical ICU Prospective, cohort 66 Infections, sepsis, in-hospital mortality ≤50 nmol/l vs >50 nmol/l 2
Higgins et al. [23] 2012 Medical, surgical ICU Prospective, cohort 196 Infections, sepsis, 30-day mortality ≤30 nmol/l vs ≥60 nmol/l 7
Lucidarme et al. [12] 2012 Medical, surgical ICU Prospective, cohort 134 30-day mortality >15- ≤30 vs ≥60 nmol/l 5
Matthews et al. [30] 2012 Medical ICU Prospective, cohort 258 In-hospital mortality ≥10- ≤32 vs 67-97 nmol/l 3
Moromizato et al. [26] 2014 Medical, surgical ICU Two-centre, retrospective, cohort 3,386 Sepsis ≤37 nmol/l vs ≥75 nmol/l 8
Nair et al. [27] 2012 Medical ICU Prospective, cohort 100 30-day-, in-hospital mortality <25 nmol/l vs ≥50 nmol/l 6
Remmelts et al. [28] 2012 Ward, medical ICU Prospective, cohort 272 30-day mortality ≤50 nmol/l vs ≥75 nmol/l 7
Su et al. [29] 2013 Medical, surgical ICU Prospective, cohort 156 30-day mortality ≤37 nmol/l vs ≥75 nmol/l 6
Venkatram et al. [4] 2011 Medical ICU Retrospective, cohort 437 Sepsis, in-hospital mortality ≤50 nmol/l vs ≥75 nmol/l 4
*Study quality assessed by the Newcastle-Ottawa scale, see S8 in Additional file 1. ICU, intensive care unit.
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one additional study was excluded because of duplicates. All
studies included in this analysis (n = 14) were prospective
cohort studies (n = 9) or had retrospective designs (n = 5).
We were not able to include all studies because they de-
scribed different outcomes like effect on delirium, anti-
microbial peptide levels and 90-day mortality [8,14,15] or
their results [16] were not formatted to allow combining the
results with the other studies. We also excluded four inter-
ventional trials because they were small in sample size and
none reported on infections, sepsis and mortality [17-20],
(S9 Figure 1 in Additional file 1).Study characteristics
Fourteen observational reports published from January
2000 until March 2014 involving 9,715 critically ill pa-
tients were included. The average serum 25 (OH)-D
level of the study population was 45 nmol/L. Mean age
was 62 years and the majority of the patients, 53%, were
male. The presence of infections was 31% and sepsis oc-
curred in 28% of the patients. The average 30-day mor-
tality in this study cohort was 17.5% and the in-hospital
mortality rate 18.4%. Characteristics of the studies are
presented in Table 1. For a complete overview of study
characteristics of studies included in the meta-analysis
see S2 Table 2 in Additional file 1.25 (OH)-D levels and infections
Five [3,21-24] of the fourteen studies reported on infec-
tions. We pooled the manually calculated RRs for the ef-
fect of low levels of 25 (OH)-D on infections (Figure 1),
including 1,967 patients. The pooled RR was 1.49 (95% CI
1.12 to 1.99).Figure 1 Forest plot of studies comparing deficient vitamin D levels w
IV, inverse variance; Vit D-, deficient vitamin D level; Vit D+, sufficient vitam25 (OH)-D levels and sepsis
The RRs in seven [4,5,22-26] of the fourteen studies were
manually calculated, involving 3,844 patients (Figure 2).
The pooled RR was 1.46 (95% CI 1.27 to 1.68).
25 (OH)-D levels and mortality
Seven of the fourteen studies reported on 30-day mortality,
with ORs either available in the articles converted to RRs
[3,5] (n = 2) or manually calculated RRs [12,23,27-29]
(n = 5), involving 2,857 patients (Figure 3). The pooled RR
was 1.42 (95% CI 1.00 to 2.02). Two studies [3,5] used a
multivariate model adjusted for age, gender, race, disease se-
verity, season and ICU type. Remmelts et al. [28] adjusted
for age and heart failure in the multivariate analysis and Nair
et al. [27] for age and disease severity. The pooled subgroup
analysis of adjusted data involving 2,572 patients demon-
strated an increased RR for 30-day mortality associated with
vitamin D deficiency by 1.76 (95% CI 1.37 to 2.26) (Figure 4).
Eight [3-5,22,24,25,27,30] of the fourteen studies reported
in-hospital mortality of 3,606 patients (Figure 5). The pooled
RR was 1.79 (95% CI 1.49 to 2.16).
Subgroup analyses per outcome based on study design
The effect on outcome in prospective study data is lower
than in retrospective data see S10 in Additional file 1,
but there were less prospective data.
Discussion
This study represents the first comprehensive systematic
review and meta-analysis focused on studies in which
the effects of vitamin D deficiency in critically ill pa-
tients on occurrence of infection, sepsis and mortality
rates are described. These results show that vitamin D
deficiency (<50 nmol/L) is associated with increase inith sufficient vitamin D levels on infection. CI, confidence interval;
in D level.
Figure 2 Forest plot of studies comparing deficient vitamin D levels with sufficient vitamin D levels on sepsis. CI, confidence interval; IV,
inverse variance; Vit D-, deficient vitamin D level; Vit D+, sufficient vitamin D level.
de Haan et al. Critical Care 2014, 18:660 Page 5 of 8
http://ccforum.com/content/18/6/660infection rate, sepsis, 30-day mortality and in-hospital
mortality in adult critically ill patients, worldwide.
The association between vitamin D status and immunity
has been already supported by a number of studies
[31-33]. However, results in healthy volunteers exposed to
experimental human endotoxaemia suggest a lack of this
association between vitamin D and inflammatory cytokine
levels [34]. Therefore, it is suggested that the differences
in the ability to produce vitamin D, may contribute to a
difference in the susceptibility to microbial infection. Our
study adds to the discussion on the association by an ob-
jectively derived pooled risk. The relation between 25
(OH)-D levels and sepsis has been described previously
[8]. Vitamin D-deficient patients are at higher risk for
blood culture positivity, which may contribute to higher
sepsis rates [3]. However, Cecchi et al. found no clear rela-
tionship on outcome between lower vitamin D levels in
septic patients when compared with a matched cohort
[16]. The most recent study by Moromizato et al. included
in our analysis specifically showed a threshold of 25 (OH)-Figure 3 Forest plot of studies comparing deficient vitamin D levels w
analysis). CI, confidence interval; IV, inverse variance; Vit D-, deficient vitamD less than or equal to 40 nmol/L to be associated with
sepsis [26]. Thus our results are in agreement with the
hypothesis that vitamin D deficiency is a contributor to
sepsis.
Some published studies [17,35] suggested an association
between vitamin D deficiency and mortality in critically ill
patients. In the study by Van den Berghe et al. both 25
(OH)-D and 1,25 (OH)-D levels were lower among non-
survivors in critically ill patients [17]. Matthews et al. noted
in their surgical ICU cohort that most deaths occurred at
vitamin D levels less than 32 nmol/L and that no deaths oc-
curred at levels higher than 65 nmol/L [30]. The CopD
study done by Durup et al. reported a reversed J-shape rela-
tion between 25 (OH)-D and all-cause mortality, suggesting
that too much and too little are deleterious. A serum 25
(OH)-D of 50 to 60 nmol/L was associated with the lowest
mortality risk [36]. The results of this meta-analysis suggest
that vitamin D levels below 50 nmol/L, increase 30-day
mortality and in-hospital mortality with 76% and 79% re-
spectively. To date, only four randomised trials in adultith sufficient vitamin D levels on 30 day-mortality (univariate
in D level; Vit D+, sufficient vitamin D level.
Figure 4 Forest plot of studies comparing deficient vitamin D levels with sufficient vitamin D levels on 30 day-mortality (multivariate analysis).
CI, confidence interval; IV, inverse variance; Vit D-, deficient vitamin D level; Vit D+, sufficient vitamin D level.
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signed to study normalisation of vitamin D levels and its
possible adverse effects such as hypercalcaemia and hyper-
calciuria [17-20]. These studies were not sufficiently pow-
ered to investigate the effects of vitamin D normalisation
and potential benefits on hard outcomes such as incidence
of severe infections and/or ICU mortality (S11 Table 3 in
Additional file 1). The recently published Lancet review
supports the relation between 25 (OH)-D deficiency and
all-cause mortality in observational studies [9]. The discrep-
ancy with the interventional studies could be due to under-
powered numbers, low dosages or short duration of
supplementation. The role for supplementation is unclear
and appropriate dose-response studies with 1,25 and 25
(OH)-D must be done. Therefore the authors? conclusion
about low vitamin D as merely a marker of disease has to
be confirmed in prospective interventional studies.
Data from biochemical and molecular studies indicate
that vitamin D, in particular its active form 1,25 (OH)-D,
has a much wider role than only the maintenance of cal-
cium homeostasis and bone health. Sufficiency of vita-
min D activity can thus also be defined by sufficient
autocrine and paracrine production of 1,25 (OH)-D at
serum 25 (OH)-D levels of at least around 75 nmol/L
[37,38]. This active form is responsible for most, if notFigure 5 Forest plot of studies comparing deficient vitamin D levels w
confidence interval; IV, inverse variance; Vit D-, deficient vitamin D level; Vitall, of the biological and pleiotropic effects including
antimicrobial actions and immunomodulatory effects of
vitamin D [7,39]. The study by Zittermann et al. demon-
strated the superiority of predicting mortality by 1,25
(OH)-D as compared to 25 (OH)-D, supporting the as-
sumption that adequately circulating 1,25 (OH)-D levels
may play a role for survival [40]. Marshall et al. empha-
sised measuring 1,25 (OH)-D instead of total 25 (OH)-D
as well; they postulated that the disease processes regu-
late vitamin D metabolism so that the low 25 (OH)-D
levels observed in disease may be merely a biomarker of
disease severity [39]. Unfortunately, the observational ar-
ticles meta-analysed in this manuscript do not consider
1,25 (OH)-D on outcomes.
Two studies [3,5] had a time lag between admission into
the ICU and vitamin D blood sampling. To illustrate the im-
portance between 25 (OH)-D time of measurement and ad-
mission, the authors conducted a sensitivity analysis
considering patients with 25 (OH)-D drawn before or after
90 days prior to hospital admission. This sensitivity analysis
showed that the association that was found between vitamin
D on outcomes was not modified by time lag.
Our study has several limitations. First, we included both
prospective and retrospective studies in this meta-analysis,
which is a matter of debate. In retrospective studies theith sufficient vitamin D levels on in-hospital mortality. CI,
D+, sufficient vitamin D level.
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this by adding a subgroup analyses per outcome based on
design, see S10 in Additional file 1. However, in the pro-
spective study data the effect on mortality is lower,
whereas the sample size in the prospective studies may
have been insufficient to show an association. The five
retrospective papers [3-5,25,26] contain large sample sizes
enabling multivariate analysis for mortality ruling out con-
founders such as age, gender, race, glomerular filtration
rate (GFR), C-reactive protein (CRP), season, disease se-
verity and so on. Second, the studies included are observa-
tional so that a causative link between hypovitaminosis D
and outcomes cannot be established. Additionally, the
variability in measured 25 (OH)-D levels is probably
multifactorial. It is possible that a random single 25 (OH)-
D measurement in ICU patients does not appropriately
reflect the vitamin D status [41]. Furthermore, alterations
in vitamin D binding protein, fluid shifts [42] and assay
variability with coefficients of variation ranging from 6%
to 13% [43] may limit applicability of single measurements
on outcome prediction used in most of the included stud-
ies. The different cutoff levels used by different studies are
based on study endpoints (for example, fracture or osteo-
porosis) done in the general population. The applicability
of these cutoff levels in the critically ill is unclear, espe-
cially because cutoff values between bone- specific and
pleiotropic endpoints are different. There is heterogeneity
in the definitions of infection and sepsis used in the in-
cluded studies, sepsis was defined varying from positive
blood cultures [3] to SIRS criteria together with a source
of infection [23] but the I2 test did not show heterogen-
eity. We only found some heterogeneity (P = 0.08) in the
forest plot combining studies with infection as outcome.
Conclusions
In conclusion, this is the first meta-analysis suggesting an
association between vitamin D deficiency and infection
and mortality in the critically ill. This information may
help to design placebo-controlled randomised clinical tri-
als on vitamin D supplementation in preventing severe in-
fections and death in the ICU.
Key messages
 25 (OH)-D deficiency is highly prevalent across
intensive care population worldwide.
 In critically ill patients, 25 (OH)-D deficiency is
associated with mortality.
 25 (OH)-D deficiency may be a risk factor for
infections and sepsis.
 We support the need for adequately powered
prospective, dose-response trials to evaluate the ef-
fect of vitamin D substitution on infection rates,
sepsis and mortality in the critically ill.Additional file
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